Lymphomatoid Papulosis — Trials

Lymphomatoid Papulosis — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03409432	Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma	completed	Phase 2	26	John ReneauOTHER	1	Aug 13, 2026	clinicaltrials
NCT01352520	SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)	active not recruiting	Phase 2	79	M.D. Anderson Cancer CenterOTHER	1	Jul 16, 2026	clinicaltrials
NCT03587844	Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients	recruiting	Phase 2	58	Memorial Sloan Kettering Cancer CenterOTHER	1	Apr 3, 2026	clinicaltrials

Data updated 22 days agoSource updated Aug 13, 2026source: clinicaltrials